Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19. | N Engl J Med;385(20): e70, 2021 11 11. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.

Merison, Tomer; Goldman, Adam; Bomze, David.

Merison T; Shamir Medical Center, Tzrifin, Israel.
Goldman A; Tel-Aviv University, Tel-Aviv, Israel davidbomze@gmail.com.
Bomze D; Tel-Aviv University, Tel-Aviv, Israel davidbomze@gmail.com.

N Engl J Med ; 385(20): e70, 2021 11 11.

Article in English | MEDLINE | ID: covidwho-1454868

Subject(s)

COVID-19; Antibodies, Monoclonal; Humans; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: N Engl J Med Year: 2021 Document Type: Article Affiliation country: NEJMc2113862

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: N Engl J Med Year: 2021 Document Type: Article Affiliation country: NEJMc2113862